| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Martin Sebastien | Director | 909 ROSE AVE, 8TH FLOOR, NORTH BETHESDA | /s/ Curtis E. Jewell, Attorney-in-Fact | 16 Jan 2026 | 0002105359 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESAB | Restricted Stock Units | Award | $0 | +231 | $0.000000 | 231 | 01 Jan 2026 | Common stock, par value $0.001 | 231 | Direct | F1, F2 | ||
| transaction | ESAB | Stock Option (right to buy) | Award | $0 | +777 | $0.000000 | 777 | 01 Jan 2026 | Common stock, par value $0.001 | 777 | $112.57 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. |
| F2 | These restricted stock units vest in a single installment on January 1, 2027. |
| F3 | These stock options vested and became exercisable on the grant date. |